AstraZeneca has sought to reassure investors that its plans to replace traditional chemotherapy with a new generation of targeted drugs are on track, as it announced full trial results at a medical congress on Monday.
阿斯利康(AstraZeneca)试图让投资者放心，该公司用新一代靶向药物取代传统化疗的计划正在如期进行。该公司周一在一个医学大会上公布了完整试验结果。
您已阅读6%（294字），剩余94%（4602字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。